Mitomycin
Showing 1 - 25 of 501
Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)
Completed
- Bladder Cancer
- intravesical mitomycin-C 40mg/20ml instillation
-
Goyang, Korea, Republic ofNational Cancer Center
Jan 30, 2023
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Urothelial Carcinoma Trial in Gainesville (Mitomycin c)
Active, not recruiting
- Urothelial Carcinoma
- Mitomycin c
-
Gainesville, FloridaUniversity of Florida
Dec 6, 2022
Pterygium Trial in Menoufia (Mitomycin c)
Completed
- Pterygium
- Mitomycin c
-
Menoufia, EgyptFaculty of Medicine, Menoufia University
Nov 16, 2022
Thrombotic Microangiopathy Associated With Mitomycin C, Treated
Recruiting
- Thrombotic Microangiopathies
-
Strasbourg, FranceService de Néphrologie, Dialyse et Transplantation - CHU de Stra
Oct 18, 2023
Lung Non-Small Cell Carcinoma, Mediastinal Tumor, Pleural Tumor Trial in Duarte (Angiography, Computed Tomography, Ethiodized
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +2 more
- Angiography
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Hepatocellular Carcinoma, Peritoneal Metastasis, Hyperthymic Trial in Chengdu (mitomycin C-based hyperthermic intraperitoneal
Recruiting
- Hepatocellular Carcinoma
- +3 more
- mitomycin C-based hyperthermic intraperitoneal chemotherapy
-
Chengdu, Sichuan, ChinaWest China Hospital
Sep 14, 2022
Myopia Trial in Damieta (Transepithelial PRK/MMC, Alcohol-Assisted PRK/MMC)
Recruiting
- Myopia
- Transepithelial PRK/MMC
- Alcohol-Assisted PRK/MMC
-
Damieta, New Damietta, EgyptEhab tharwat
Sep 17, 2022
Presbyopia Trial in Bloomington, Dallas, San Antonio (Mitomycin c, Raindrop Near Vision Inlay)
Terminated
- Presbyopia
- Mitomycin c
- Raindrop Near Vision Inlay
-
Bloomington, Minnesota
- +2 more
Aug 15, 2022
Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Squamous Cell Carcinoma, Head and Neck
-
Saint Louis, MissouriWashington University School of Medicine
Jun 21, 2022
Esophageal Stenosis, Anastomotic Stenosis Trial in Philadelphia (Mitomycin C, Control)
Withdrawn
- Esophageal Stenosis
- Anastomotic Stenosis
- Mitomycin C
- Control
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 1, 2022
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial
Available
- Urothelial Cancer of Renal Pelvis
- +5 more
- Mitomycin for pyelocalyceal solution
- (no location specified)
Aug 5, 2022
Bladder Cancer Trial in Aarhus (Mitomycin c)
Active, not recruiting
- Bladder Cancer
- Mitomycin c
-
Aarhus, DenmarkAarhus University Hospital
Aug 5, 2022
Glaucoma, Open-Angle Trial in Oakville (XEN 63)
Recruiting
- Glaucoma, Open-Angle
- XEN 63
-
Oakville, Ontario, CanadaPrism Eye Institute
Sep 26, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2022
Glaucoma, Primary Open Angle Glaucoma, Secondary Glaucoma Trial in Worldwide (drug, other, procedure)
Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)
Active, not recruiting
- Diseases of Oesophagus Stomach and Duodenum
- Dexamethasone
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 7, 2022
Colorectal Cancer, Chemo Effect, Surgery Trial (Mitomycin, Lobaplatin)
Not yet recruiting
- Colorectal Cancer
- +4 more
- Mitomycin
- Lobaplatin
- (no location specified)
Feb 18, 2022
Locally Advanced Anal Canal Cancer Trial in France (5Fluorouracile and Mitomycin-C, Simultaneously integrated boost of intensity
Active, not recruiting
- Locally Advanced Anal Canal Cancer
- 5Fluorouracile and Mitomycin-C
- Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
-
Angers, France
- +7 more
Dec 7, 2022
Lower Urinary Tract Symptoms After Intravesical Therapy
Recruiting
- Chemotherapy Effect
- +3 more
- Validated questionnaires
-
Munich, Bavaria, GermanyNikolaos Pyrgidis
May 3, 2023
Severe Neutropenia After HIPEC Using Mitomycin-C
Recruiting
- Colorectal Cancer Metastatic
- +3 more
- Intraoperative blood and peritoneal fluid samplings during HIPEC
-
Seoul, Korea, Republic ofDivision of Colon and Rectal Surgery, Department of Surgery, Gan
Aug 21, 2022
Upper Urinary Tract Carcinoma Trial
Not yet recruiting
- Upper Urinary Tract Carcinoma
- (no location specified)
Feb 7, 2023
Corneal Opacity Trial in San Diego (Mitomycin-C, Fluorometholone 1% topical ocular steroid)
Active, not recruiting
- Corneal Opacity
- Mitomycin-C
- Fluorometholone 1% topical ocular steroid
-
San Diego, CaliforniaNavy Warfighter Refractive Surgery Center
Apr 14, 2022
Punctal Stenosis Trial in Damieta (3-snip punctoplasty, 3-snip punctoplasty and Mitomycin C)
Completed
- Punctal Stenosis
- 3-snip punctoplasty
- 3-snip punctoplasty and Mitomycin C
-
Damieta, New Damietta, EgyptEhab tharwat
Oct 15, 2022
Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)
Recruiting
- Peritoneal Carcinomatosis
- Mitomycin C, flat dose 40 mg
- Mitomycin C, weight-based dose 12.5 mg/m2
-
Lexington, KentuckyUniversity of Kentucky
Mar 1, 2022